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ABSTRACT
Invertebrate RNA viruses are targets of the host
RNA interference (RNAi) pathway, which limits virus
infection by degrading viral RNA substrates. Sev-
eral insect RNA viruses encode suppressor proteins
to counteract this antiviral response. We recently
demonstrated that the dsDNA virus Invertebrate iri-
descent virus 6 (IIV-6) induces an RNAi response in
Drosophila. Here, we show that RNAi is suppressed
in IIV-6-infected cells and we mapped RNAi sup-
pressor activity to the viral protein 340R. Using bio-
chemical assays, we reveal that 340R binds long
dsRNA and prevents Dicer-2-mediated processing of
long dsRNA into small interfering RNAs (siRNAs).
We demonstrate that 340R additionally binds siRNAs
and inhibits siRNA loading into the RNA-induced si-
lencing complex. Finally, we show that 340R is able
to rescue a Flock House virus replicon that lacks its
viral suppressor of RNAi. Together, our findings in-
dicate that, in analogy to RNA viruses, DNA viruses
antagonize the antiviral RNAi response.
INTRODUCTION
Recognition of double-stranded (ds) RNA is critical for
many cellular processes, including gene regulation, RNA
transport and RNA editing. Most dsRNA-protein inter-
actions are established by proteins that contain a canoni-
cal dsRNA-binding domain (dsRBD), which binds dsRNA
in a sequence-independent manner (1,2). RNA interfer-
ence (RNAi) is a dsRNA-initiated mechanism for post-
transcriptional gene silencing that is guided by small in-
terfering RNAs (siRNAs) and requires dsRBD-containing
proteins at several stages (3,4).
The RNAi pathway serves as a cellular defense mecha-
nism that destroys viral RNA in diverse eukaryotes, includ-
ing plants, fungi, nematodes, insects and mammals (5–8).
InDrosophila, cytoplasmic Dicer-2 (Dcr-2), which contains
two RNase III motifs and a single dsRBD, recognizes vi-
ral dsRNA as non-self and processes it into viral siRNAs
(vsiRNAs), RNAduplexes of 21 nt that contain 2 nt 3′ over-
hangs (5,9). A heterodimer composed of the dsRBD adap-
tor protein R2D2 and Dcr-2 subsequently binds vsiRNA
duplexes tomediate their loading intoArgonaute-2 (AGO2)
in the RNA-induced silencing complex (RISC). Within
RISC, vsiRNAs guide the recognition and cleavage of fully
complementary viral target RNA by AGO2 (9,10).
Several insect RNA viruses have evolved viral suppres-
sors of RNAi (VSRs) to antagonize the initiation phase
of the antiviral RNAi pathway (9). For example, the 1A
protein of Drosophila C virus (DCV) contains a canoni-
cal dsRBD that binds long dsRNA and prevents Dcr-2-
mediated vsiRNA biogenesis (11). The B2 protein of Flock
House virus (FHV) and the VP3 proteins of Drosophila
X virus and the mosquito-specific Culex Y virus interfere
with the insect RNAi pathway by sequestering long dsRNA
as well as siRNAs (12–16). These VSRs may thus inhibit
the production of vsiRNAs and prevent their incorporation
into RISC.
In RNA virus-infected plants, viral dsRNA is processed
by the Dicer-like (DCL) proteins DCL2, DCL3 and DCL4,
which generate viral small RNAs of 22-, 24- and 21-nt in
size, respectively (5). The P19 protein of tombusviruses is
one of the best-characterized VSRs in plants. P19 specifi-
cally binds 21-nt sized siRNAs (17–20) and thereby prevents
siRNA incorporation into RISC (21). A similar strategy
is used by several other plant RNA viruses (22,23). Sweet
potato chlorotic stunt virus prevents siRNA loading into
RISC via an alternative mechanism. This single-stranded
RNA virus encodes a viral RNase III protein that processes
siRNAs into 14-bp small RNA duplexes, which are non-
functional in RNAi (24). Likewise, the RNase III of the
dsDNA virus Heliothis virescens ascovirus-3e cleaves long
dsRNA in the tobacco budworm (Heliothis virescens) (25).
Thus, the RNase III proteins of two unrelated viruses in-
terfere with RNAi, either by inhibiting vsiRNA production
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through destruction of Dcr-2 substrates or by preventing
the incorporation of functional vsiRNAs into RISC.
Importantly, some insect and plant RNA viruses inhibit
the RNAi pathway at the effector phase (9,23). For exam-
ple, the Cricket paralysis virus (CrPV) 1A and Nora virus
VP1 proteins antagonize the enzymatic activity of AGO2 in
Drosophila (26,27). Similarly, the Cucumber mosaic virus
2b protein inhibits the endonuclease activity of AGO1 in
plants (28). Plant AGO1 function is also suppressed by
the P0 and P38 proteins of Beet western yellows virus and
Turnip crinkle virus, respectively (29–32). These studies in-
dicate that unrelated viruses have evolved VSRs that inhibit
the catalytic activity of RISC and thus highlight the critical
role of Argonaute proteins in antiviral defense.
Over the last years, several studies revealed that different
classes of RNA viruses are both targets and suppressors of
RNAi in Drosophila (11,13,33,34). Recently, we and others
showed that RNAi also provides antiviral defense against
DNAviruses in vivo (35,36). Indeed,Dcr-2-dependent vsiR-
NAs were generated in Invertebrate iridescent virus 6 (IIV-
6)-infected flies and, accordingly, AGO2 and Dcr-2 mutant
flies were more susceptible to IIV-6 infection than wild-type
(WT) flies. However, it remained unknown whether DNA
viruses antagonize theDrosophila antiviral RNAi response.
In the present study, we investigated whether IIV-6 sup-
presses RNAi. We demonstrate that the IIV-6 340R pro-
tein inhibits RNA silencing when RNAi is induced by long
dsRNA as well as by siRNA duplexes. In a series of bio-
chemical assays, we further demonstrate that 340R binds
RNA duplexes to prevent siRNA biogenesis and to inhibit
RISC loading. Our findings indicate that DNA viruses are
targets and suppressors of the antiviral RNAi response.
MATERIALS AND METHODS
Cells and viruses
Drosophila melanogaster S2 cells were cultured as described
previously (27).DCVand IIV-6were propagated and titered
as described previously (11,35).
Plasmids
A proteinase K-treated IIV-6 virus stock was used as a
template to amplify the 340R and 142R coding sequences,
using primers that contain flanking XbaI restriction sites
and introduce a Drosophila Kozak sequence (Supplemen-
tary Table S1). PCRproducts were subsequently cloned into
the XbaI site of pAc5-V5-His B (Life Technologies), yield-
ing plasmids that encode C-terminal V5 epitope-tagged
proteins. Open reading frame (ORF) 340R mutant plas-
mids were generated by site-directed mutagenesis using the
primers from Supplementary Table S1. The orientation and
sequence of the selected clones was confirmed by DNA se-
quencing. Plasmids pAWH CrPV-1A, pMT-Luc and pMT-
Ren were described previously (11,26). The pMT Renilla
hairpin plasmid was kindly provided by R. Zhou (37). Plas-
mids encoding FHV replicons were described previously
(16).
Plasmids encoding maltose-binding protein (MBP) fu-
sion proteins were generated for the production of recom-
binant protein in Escherichia coli. The sequences coding
for DCV 1A, WT 340R and the 340R mutants K89A and
dsRBD100 were polymerase chain reaction (PCR) ampli-
fied and cloned as EcoRI-SalI fragments into pMAL-C2X
(New England Biolabs) (see Supplementary Table S1 for
primer sequences).
RNAi reporter assays in S2 cells
The ability of IIV-6 to suppress RNAi-mediated silencing
of firefly luciferase (Fluc) expression was analyzed as pre-
viously described for DCV (11). Briefly, 2.5 × 104 S2 cells
were seeded in a 96-well plate andmock-infected or infected
with IIV-6 or DCV at an multiplicity of infection (MOI) of
0.1 or 0.01. Twenty-four hours after infection, cells were co-
transfected with 12.5 ng pMT-Luc, 3 ng pMT-Ren, 50 ng
empty pAc5-V5-His B plasmid and 10 ng dsRNA target-
ing either Fluc (dsFluc) or green fluorescent protein (GFP)
(non-specific control, dsCtrl), using Effectene Transfection
Reagent (Qiagen). Twenty-four hours after transfection, ex-
pression of the Fluc and Renilla luciferase (Rluc) reporters
was induced by addition of 0.5 mM CuSO4 to the culture
supernatant. Cell lysates were prepared after an additional
18-h incubation and luciferase activities were measured us-
ing the Dual luciferase reporter system (Promega).
Reporter assays in which RNAi was induced by dsRNA
feeding were performed in S2R+ cells in a 96-well format.
3.0 × 104 S2R+ cells were seeded and transfected the next
day with 12.5 ng pMT-Luc, 3 ng pMT-Ren and either 50 ng
pAc-VSR to express one of the viral proteins or the empty
pAc vector. Two days after transfection, 400 ng dsRNAwas
added to the culture medium. Expression of reporter genes
was induced at 8 h after dsRNA treatment and luciferase
activities were measured the next day (38).
RNAi reporter assays in which RNAi was induced byRe-
nilla hairpin RNA were performed in S2 cells. 3.0 × 105
S2 cells were seeded in a 24-well plate and transfected the
next day with 12 ng pMT-Ren, 50 ng pMT-Luc, 200 ng
pAc-VSRplasmid and eitherwith 75 ng of copper-inducible
pMT hairpin-Renilla plasmid or, as non-silencing control,
empty pMT plasmid. Expression of the Renilla hairpin
RNA and the luciferase reporters was induced 2 days post-
transfection by addition of copper sulfate to the culture su-
pernatant and luciferase activities were measured at 18 h
post-induction.
For the sequential co-transfection, 3.0× 105 S2 cells were
seeded in 24-well plates. The next day, S2 cells were trans-
fected with 100 ng pCoBlast (Life Technologies) and 300
ng of pAc-VSR plasmid. Forty-eight hours after transfec-
tion, the cells were transferred to 96-well plates in medium
containing 25 g/ml of blasticidin S (Life Technologies) to
select for cells that express the viral proteins. The next day,
a second transfection was performed with 12.5 ng pMT-
Luc, 3 ng pMT-Ren, 50 ng pAc-empty carrier plasmid and 2
pmol of Fluc-specific siRNA (siFluc) or non-silencing con-
trol siRNA (siCtrl). The reporters were induced 24 h post-
transfection and luciferase activities weremeasured the next
day. For all reporter assays in which Fluc expression was
silenced, Fluc counts were normalized to Rluc counts and
expressed as fold silencing relative to control (empty vector)
treatment, and vice versawhenRluc expressionwas silenced
(38).
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Western blot analysis
To analyze protein expression from VSR expression plas-
mids, 3.0 × 105 S2 cells were seeded in a 24-well plate.
Twenty-four hours after seeding, cells were transfected with
500 ng of a VSR expression plasmid or an empty con-
trol plasmid using Effectene Transfection Reagent (Qia-
gen) and harvested at 3 days post-transfection. To ana-
lyze protein expression from VSR expression plasmids in
our RNAi reporter assays, we pooled the cell lysates of
10 individual wells of a 96-well plate. Proteins were sepa-
rated on a 12.5% denaturing polyacrylamide gel and trans-
ferred to an 0.2-m nitrocellulose membrane (Bio-Rad).
The membrane was stained by subsequent incubations in
anti-V5 mouse monoclonal antibodies (Life Technologies)
and Alexa Fluor 680-conjugated goat anti-mouse anti-
bodies (LI-COR Biosciences). As a loading control, the
same membrane was probed with anti--tubulin antibod-
ies (AbD Serotec) and Alexa Fluor 800-conjugated goat
anti-rat antibodies (LI-COR Biosciences). Bound antibod-
ies were visualized on an Odyssey infrared imager (LI-COR
Biosciences).
Homology modeling
To predict the protein structure of 340R, we generated a ho-
mology model using the YASARA & WHAT IF Twinset
under default settings (39,40). The experimentally solved
protein structure of TRBP2 (Protein database accession
3ADL) and Aquifex aeolicus RNase III (PDB 2NUG)
were used as a template (41,42). The model contained
residues 1–112 of 340R (out of a total length of 173 aa),
of which residues 1–37 were modeled after Aa-RNase III
and residues 20–112 after TRBP2.
Production and purification of recombinant proteins
Plasmids encoding MBP fusion proteins were transformed
into the E. coli BL21 (DE3) strain and expression of recom-
binant proteins was induced with 1 mM isopropyl -D-1-
thiogalactopyranoside (IPTG) at an OD600 of 1.2. The cul-
tures were incubated for 3 h at 37◦C for pMAL-empty and
pMAL-DCV 1A and for 4.5 h at 25◦C for pMAL-340R.
Fusion proteins were affinity-purified using amylose resin
according to themanufacturer’s protocol (NewEngland Bi-
olabs). Recombinant proteins were transferred to a dialy-
sis membrane (molecular weight cut-off 12–14 kDa) and
dialyzed to buffer (20 mM Tris-HCl, 0.5 mM ethylenedi-
aminetetraacetic acid, 5 mMMgCl2, 1 mM DTT, 140 mM
NaCl, 2.7 mM KCl). Recombinant proteins were stored as
aliquots at –80◦C in dialysis buffer containing 30% glycerol.
Protein concentrations were determined by a Bradford as-
say (Bio-Rad).
Electrophoretic mobility shift assays (EMSAs)
Radiolabeled probes for EMSAs were generated as de-
scribed before (43). Uniformly labeled 126-nt blunt dsRNA
was generated by in vitro transcription of T7 promoter-
flanked PCR fragments using T7 RNA polymerase in the
presence of -32P-[UTP]. After annealing of the two radio-
labeled RNA strands, unincorporated nucleotides were re-
moved using a G-25 Sephadex column (Roche) and dsRNA
was purified from an 8% native polyacrylamide gel. Syn-
thetic 21-nt siRNAs containing 2-nt 3′ overhangs and 19-
nt blunt dsRNAs (43) were end-labeled with  -32P-[ATP]
using T4 polynucleotide kinase (Roche) and purified on a
G-25 Sephadex column.
EMSAs were performed as described previously (11).
Briefly, radiolabeled 126-nt long dsRNA (5 ng), 19-nt
dsRNA or siRNA duplexes (1 nM) were incubated with
different concentrations of recombinant proteins for 1 h at
room temperature. Long dsRNA and siRNA EMSAs were
analyzed on 6%and 12%native polyacrylamide gels, respec-
tively. Gels were exposed to aKodak BiomaxXARfilm and
radioactive signals were quantified with ImageJ software.
Dicer and slicer assays
To analyze processing of long dsRNA into siRNA, we per-
formed in vitro Dicer assays in Drosophila S2 cell lysate as
described before (27,44). 11 × 106 S2 cells were seeded in
T75 flasks and 1 day after seeding, cells were either mock-
infected or infected with IIV-6 at anMOI of 1.0 or 0.1. Two
days post-infection, cells were harvested and homogenized
in lysis buffer [30mMHEPES-KOH, 100mMKOAc, 2mM
Mg(OAc)2, 5 mM DTT and complete protease inhibitor
mixture (Roche)] for 1 h on ice. Protein concentrations of S2
cell extracts were analyzed by a Bradford assay (Bio-Rad)
and lysates were frozen at –80◦C. Before analyzingDicer ac-
tivity, cell extracts were thawed on ice and centrifuged for 30
min at 16 000 × g at 4◦C to remove cell debris.
To analyze AGO2 target RNA cleavage, we performed in
vitro Slicer assays inDrosophila embryo lysates as described
previously (27,44).
FHV replicon assay
S2 cells were seeded in a 24-well plate at a density of 3.0
× 105 cells per well. The next day, cells were transfected
with 100 ng of plasmid encoding either the WT FHV repli-
con or the B2-deficient replicon (FHV B2) along with ei-
ther 300 ng of pAc-VSR plasmid or empty control plas-
mid. Two days after transfection, 0.5mMCuSO4 was added
to the culture medium to induce transcription of the FHV
replicon. The following day, cells were harvested and total
RNAwas isolated using Isol-RNALysis reagent. RNAwas
treated with DNase I (Life Technologies) and cDNA syn-
thesis was performed using TaqMan Reverse Transcription
Reagents (Life Technologies) and a strand-specific FHV
primer tagged with a 5′ T7 promoter sequence (43). Follow-
ing cDNA synthesis, qPCR analysis was performed using a
combination of a T7 promoter primer and an FHV-specific
forward primer. Data were normalized to Rp49 (RpL32),
for which strand-specific quantitative reverse transcriptase-
PCR (qRT-PCR) assays were run in parallel (43), and pre-
sented as fold change relative to empty vector control.
RESULTS
RNAi is suppressed in IIV-6-infected cells
We and others recently reported that the dsDNA virus IIV-
6 triggers an antiviral RNAi response inDrosophila (35,36).
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To investigate whether IIV-6 antagonizes the host RNAi re-
sponse, we performed RNAi reporter assays in Drosophila
S2 cells. In these well-established assays, RNAi-mediated si-
lencing of a Fluc reporter gene is induced by Fluc-specific
long dsRNA or siRNAs (11,38).
We first tested whether RNAi is suppressed in IIV-6-
infected S2 cells. As a positive control, we included the
positive-sense RNA virus DCV, which encodes a VSR and
inhibits RNAi in infection (11). Co-transfection of reporter
plasmids along with Fluc-specific long dsRNA resulted in
efficient silencing of the Fluc reporter in mock-infected cells
(240-fold, Figure 1A). In contrast, in IIV-6-infected cells,
silencing of the Fluc reporter was suppressed in an MOI-
dependent manner, to 118-fold at an MOI of 0.01 and to
28-fold at an MOI of 0.1 (Figure 1A; P = 0.061 and P =
0.004, respectively). As observed before (11), DCV also sup-
pressed RNAi in an MOI-dependent manner (Figure 1A).
Together, these results indicate that the RNAi pathway is
suppressed in IIV-6-infected cells.
The IIV-6 340R protein is a suppressor of RNAi
IIV-6 is a large, complex virus with a 212-kb genome that
contains 211 predicted ORFs (45,46).We therefore browsed
the IIV-6 genome for ORFs that encode proteins with pre-
dicted domains or motifs that might account for the ob-
servedRNAi suppressor activity. A candidate is ORF142R,
which encodes a putative RNase III thatmight degrade siR-
NAs or long dsRNA substrates for Dcr-2, as was observed
for RNase III proteins of other viruses (24,25). Another
candidate VSR is 340R, which contains a predicted canoni-
cal dsRBD. Such domains have also been observed in other
VSRs (11,47). The 142R and 340Rproteins are conserved in
different genera within the Iridoviridae family (46,48), sug-
gesting that these proteins have important functions in the
viral life cycle.
To analyze whether 142R and 340R inhibit the RNAi
pathway, we cloned the individual ORFs into expression
plasmids for RNAi reporter assays. S2 cells were transfected
with the expression plasmids along with the reporter plas-
mids. Two days after transfection, dsRNAwas added to the
culture supernatant to induce RNAi, thus allowing expres-
sion of viral proteins before induction of RNAi. The CrPV
1A protein, which suppresses the RNAi pathway by antag-
onizing RISC enzymatic activity, served as a positive con-
trol (26). The dsRBD protein 340R suppressed RNAi to
background levels (compared with 12-fold silencing for the
empty control vector, P ≤ 0.001), similar to CrPV 1A (Fig-
ure 1B, P ≤ 0.001). In contrast, we did not observe VSR
activity for the predicted RNase III 142R (Figure 1B). Al-
though we readily detected protein expression of 142R and
340R in transfected S2 cells by western blot analysis (Figure
1C), 142Rwas expressed at lower levels than 340R. Increas-
ing the amount of transfected 142R expression plasmid led
to a mild increase in protein levels. However, also under
these conditions, we could not detect VSR activity for 142R
(Supplementary Figure S1A). To confirm these results, we
performed an RNAi reporter assay in which a Renilla lu-
ciferase (Rluc) reporter is silenced by an Rluc-specific hair-
pinRNAexpressed froma copper-inducible promoter. Also
in this assay, 340R efficiently suppressed RNAi (Figure 1D,
P = 0.003), whereas 142R was unable to do so.
To investigate whether 340R inhibits the RNAi pathway
downstream of siRNA production, we performed an assay
in which we induced RNAi with siRNAs instead of long
dsRNA. We found that 340R efficiently inhibited siRNA-
inducedRNAi (Figure 1E; 7.7-fold silencing comparedwith
27-fold for the empty control plasmid, P ≤ 0.001), indicat-
ing that this VSR is capable of suppressing the RNAi path-
way at a stage downstream of Dcr-2-dependent siRNA pro-
duction.
The dsRBD of 340R is required for RNAi suppression
The IIV-6 340R gene encodes a 23-kDa protein that con-
tains a 70-aa dsRBD flanked by a 30-aa N-terminal se-
quence and a 73-aa C-terminal sequence. Alignment of the
the dsRBD of 340R to the dsRBDs of DCV 1A and cel-
lular proteins from different model organisms shows that
conserved amino acids are present throughout the motif
(Figure 2A). Homology modeling suggests that the dsRBD
of 340R adopts the expected  topology, in which
two  helices are packed along a three-stranded antipar-
allel  sheet, and that the dsRBD is preceded by an N-
terminal helical structure (Figure 2B). Based on these anal-
yses, we selected for site-directed mutagenesis four highly
conserved residues (L35Y, F63A and AA92LL) and two
residues within a region expected to interact with dsRNA
(K86A and K89A) (Figure 2A and B and Supplementary
Figure S2). In addition, we generated a C-terminally trun-
cated version of 340R, consisting of the N-terminal 100-aa
that contains the complete dsRBD (dsRBD100).
Western blot analysis verified that all mutant proteins
were expressed in transfected S2 cells, albeit at different
levels relative to the WT protein (Figure 2C). We subse-
quently analyzed VSR activity of WT and mutant 340R
in reporter assays in which RNAi was induced by feeding
of long dsRNA. In these assays, WT 340R almost com-
pletely blocked RNAi (Figure 2D; 1.4-fold silencing com-
pared with 11-fold for the empty control vector, P≤ 0.001).
All tested mutants lost VSR activity relative to WT 340R
(Figure 2D). Mutation of residues predicted to be involved
in dsRNA binding reduced silencing to 3.6-fold (K86A, P
≤ 0.001) and 8.2-fold (K89A, P= 0.074) (Figure 2D). Loss
of VSR activity of the conserved residue mutants AA92LL
and L35Ymight result from reduced expression levels (Fig-
ure 2C), perhaps due to destabilizing effects of the substitu-
tions on the local protein structure (Supplementary Figure
S2).
To increase VSR protein levels in our RNAi reporter
assays, we increased the amount of transfected L35Y and
AA92LL expression plasmids (Supplementary Figure S2B
and S2C, respectively). L35Y expression was increased to
WT 340R levels under several conditions, but this did not
result in detectable VSR activity (Supplementary Figure
S2B). For the AA92LL mutant, we only observed a slight
increase in protein levels, which was not sufficient for sup-
pression of RNAi (Supplementary Figure S2C). Similar to
the 340R point mutants, dsRBD100 did not suppress RNAi
(Figure 2D). Since this construct was expressed at lower lev-
els than WT 340R, we repeated the assay with increasing
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Figure 1. IIV-6 encodes a suppressor of RNAi. (A) dsRNA-induced RNAi reporter assay in virus-infectedDrosophila S2 cells. S2 cells were mock-infected
(-) or infected with either IIV-6 or DCV at the indicated MOI. Fluc and Renilla luciferase (Rluc) reporter plasmids were transfected along with dsRNA
targeting Fluc (dsFluc) or a non-specific control sequence (dsCtrl) and 3 days after transfection, luciferase activities were measured. (B) RNAi reporter
assay in S2R+ cells expressing individual viral proteins. Cells were transfected with luciferase reporter plasmids along with control plasmid (empty) or
expression plasmids encoding the indicated viral proteins. CrPV 1A was included as a positive control. Two days post-transfection, RNAi was induced by
adding long dsRNA to the culture supernatant. (C) Western blot analysis of V5 epitope-tagged 340R and 142R in transfected S2 cells. Viral proteins were
detected using anti-V5 antibodies (-V5); polyclonal anti--tubulin (-Tub) antibody was used as a loading control. Molecular mass (in kDa) is indicated
on the left of the image. The predicted molecular weights for 340R and 142R are 23 and 37 kDa, respectively. The asterisk (*) indicates a 340R-specific
processing or degradation product. (D)Renilla hairpin-induced RNAi reporter assay. S2 cells were transfected with luciferase reporter plasmids, expression
plasmids for the indicated viral proteins and either a plasmid that encodes a Renilla hairpin RNA (hairpin-Renilla) or an empty plasmid control (Ctrl).
(E) siRNA-induced RNAi reporter assay in S2 cells. Cells were transfected with plasmids encoding the indicated viral proteins followed by transfection of
luciferase reporter plasmids along with siRNAs that target the Fluc reporter (siFluc) or non-silencing control siRNAs (siCtrl). For all reporter assays in
which Fluc expression was silenced, Fluc counts were normalized to Rluc counts and expressed as fold silencing relative to control treatment and vice versa
when Rluc expression was silenced. Fold silencing in the non-silencing controls (dsCtrl or siCtrl) was set to one for all panels. Bars in all panels represent
the means and standard deviations of three independent samples. Difference in RNAi efficiency compared to controls (dark gray bars) was analyzed by
one-way ANOVA followed by a post hoc Dunnett’s test. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ns, not significant.
amounts of plasmid. However, although dsRBD100 reached
similar protein levels as WT 340R under these conditions,
dsRBD100 did not inhibit silencing of the reporter, indicat-
ing that the dsRBD by itself is insufficient to exert VSR ac-
tivity (Supplementary Figure S1D).
We next performed an RNAi reporter assay in which
RNAi is induced by siRNA transfection and included
dsRBD100 as well as the K89A mutant (Figure 2E). As
observed before (Figure 1E), WT 340R, as well as the
positive control CrPV 1A, efficiently suppressed siRNA-
induced RNAi (11- and 1.2-fold silencing, respectively,
compared with 44-fold for the empty vector). The K89A
and dsRBD100 mutants completely lost VSR activity (47-
and 43-fold silencing, respectively), suggesting that suppres-
sion of siRNA-induced RNAi requires the dsRNA-binding
activity of 340R as well as its 73-aa C-terminal domain.
340R binds long dsRNA and siRNA duplexes
To directly analyze dsRNA binding by 340R, we performed
EMSAs using different dsRNA substrates. Full-length WT
340R and the VSR-defective mutants K89A and dsRBD100
were fused to MBP and affinity-purified from E. coli. We
first tested whether these recombinant proteins can bind ra-
dioactively labeled, 126-bp long dsRNA. As positive con-
trol, we included recombinantMBP-DCV 1A. As expected,
no shift in mobility of long dsRNA on native polyacry-
lamide gels was observed with increasing concentrations
of MBP (Figure 3A, compare lanes 2–4 with lane 1). By
contrast, addition of DCV 1A resulted in protein-dsRNA
complex formation (Figure 3A, lane 5), which is in line
with previous observations (11,27). Similarly, WT 340R
bound dsRNA in a dose-dependent manner (Figure 3A,
lanes 6–10). Interestingly, the K89Amutant could still bind
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Figure 2. Viral protein 340R requires a functional dsRBD to suppress RNAi. (A) Alignment of the dsRBD of 340R (aa 30–100) to the dsRBDs of
proteins from different model organisms and to the dsRBD of DCV 1A. Red boxes indicate residues that interact with dsRNA in structural analyses of the
second dsRBD of Xenopus laevis RNA-binding protein A (Xl RBPA2) (56). Residues predicted to be involved in RNA binding or conserved amino acids
were selected for site-directed mutagenesis. Position of secondary structures are indicated above the alignment. (B) Homology model of 340R in complex
with dsRNA. The protein is shown in cartoon-view with the WT residue K89 shown in red (left panel) or with the WT residue shown in green and the
mutant residue (Alanine) shown in red (right panel). The RNA is shown in ball-and-stick view, without atomic details (left) and with all atoms (right). The
side-chain of residue K89 is positioned toward the phosphate backbone of the RNA and likely binds dsRNA through an electrostatic interaction of the
positively charged Lysine with the negatively charged phosphates. The substitution of this Lysine into the small and hydrophobic Alanine is likely to abolish
the interaction. See Supplementary Figure S2 for other residues selected for site-directed mutagenesis. (C) Western blot analysis of V5 epitope-tagged WT
and mutant 340R from transfected S2 cells. Proteins were detected using anti-V5 antibodies (-V5) or, as a loading control, using anti--tubulin (-Tub)
antibodies. Molecular mass (in kDa) is indicated on the left of the image. The predicted molecular weight for dsRBD100 is 14.7 kDa. FL, full-length.
The asterisk (*) indicates a 340R-specific processing or degradation product. (D) dsRNA-induced RNAi reporter assay. The experiment was performed as
described in the legend to Figure 1B, using expression plasmids forWT andmutant 340R. (E) siRNA-inducedRNAi reporter assay. Sequential transfection
was performed as described in the legend to Figure 1E, using expression plasmids for WT and mutant 340R and CrPV 1A. Difference in RNAi efficiency
compared to controls (dark gray bars) was analyzed by one-way ANOVA followed by a post hoc Dunnett’s test. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ns,
not significant.
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Figure 3. 340R binds long dsRNA and duplex siRNAs. (A) EMSA of 126-nt blunt dsRNA with WT 340R and the K89A and dsRBD100 mutants. Buffer
only (-, lane 1) and decreasing concentrations ofMBP were included as negative controls (lanes 2–4; 10, 3.2 and 0.4 M). AnMBP-DCV 1A fusion protein
was included as positive control (lane 5; 0.1 M). WT and K89A 340R were tested in 2-fold serial dilutions starting at 0.4 M (WT, lanes 6–10) and 3.2
M (K89A, lanes 11–15). dsRBD100 340R protein was tested in 10-fold dilutions starting at 10 M (lanes 16–18). (B) Quantification of the fraction bound
probe at different protein concentrations for WT 340R (black line) and the K89A mutant (gray line). Data represent means and standard deviations of
three independent experiments. (C) EMSA of 21-nt siRNAs containing 2-nt 3′ overhangs withMBP (lane 2; 8 M) and 2-fold serial dilutions of WT 340R
(lanes 3–8; starting at 2 M), and the K89A and dsRBD100 mutants (lanes 9–13 and 14–18, respectively; starting at 8 M). A representative experiment
of three independent experiments is shown in panels A and C. (D) Quantification of the fraction bound siRNA at different protein concentrations for WT
340R (black line) and the K89A mutant (gray line). Data represent means and standard deviations of three independent experiments. (E) EMSA of 19-nt
blunt dsRNA with decreasing amounts of recombinant proteins. Protein concentrations are as described in panel (C). (F) Quantification of the fraction
bound 19-nt blunt dsRNA probe at different protein concentrations for WT 340R (black line) and the K89A mutant (gray line).
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long dsRNA, although 8-fold higher protein concentrations
were required for a complete dsRNA shift (Figure 3A, lanes
11–15). Indeed, WT 340R had a ∼12-fold higher affinity
for long dsRNA than the K89A mutant (dissociation con-
stants of 138.8 ± 34.0 nM and 1626 ± 412.2 nM, respec-
tively, Figure 3B). No dsRNA-binding activity was detected
for dsRBD100, even when a 25-fold higher protein concen-
tration was tested (Figure 3A, lanes 16–18). These results
are in line with the results from the RNAi reporter assay, in
which we observed slight VSR activity for theK89Amutant
and a lack of VSR activity for dsRBD100 (Figure 2D).
We next used EMSAs to analyze whether 340R has bind-
ing affinity for siRNA duplexes. Synthetic 21-nt siRNA du-
plexes that contain 2-nt 3′ overhangs shifted after incuba-
tion with increasing amounts ofWT 340R (Figure 3C, lanes
3–8) and the K89Amutant (Figure 3C, lanes 9–13), indicat-
ing that these proteins are able to bind siRNAs. No protein-
siRNA complexes were formed with either MBP (Figure
3C, lane 2) or dsRBD100 (Figure 3C, lanes 14–18). Simi-
lar to the long dsRNA binding assay, higher concentrations
of the K89A mutant were required to observe an siRNA
shift. Accordingly, WT 340R had higher affinity for siRNA
duplexes than the K89A mutant (dissociation constants of
717.7± 97.8 nM and 6353± 699.5 nM, respectively, Figure
3D).
To analyze whether the 3′ overhangs are required for
efficient siRNA binding, we used a 19-nt blunt dsRNA
probe in EMSAs (Figure 3E). These experiments revealed
that both WT and K89A mutant 340R bind 19-nt blunt
dsRNA in a dose-dependent manner (Figure 3E, lanes 3–8
and 9–13, respectively), with dissociation constants of 1171
and 6112 nM, respectively (Figure 3F). The observation
that both WT and K89A mutant 340R had similar binding
affinities for siRNAs and 19-nt blunt dsRNA (Supplemen-
tary Figure S3), indicate that the 2-nt 3′ overhangs of siR-
NAs are not essential for efficient siRNA binding. Taken
together, these results show that WT 340R efficiently binds
both long and short dsRNA, as well as siRNA duplexes.
340R inhibits Dcr-2-dependent dsRNA processing
Our data show that 340R interacts with dsRNA and that
the dsRBD and C-terminus are required for its VSR activ-
ity. The dsRNA-binding activity of 340Rmay inhibit RNAi
at two stages. First, by binding to dsRNA, itmay shield long
dsRNA from processing by Dcr-2. Second, by sequestering
siRNAs, it may prevent incorporation of small RNAs into
RISC. We performed in vitro Dicer assays to test whether
dsRNA processing is inhibited in lysates of IIV-6-infected
cells. In these assays, we analyzed cleavage of a radiola-
beled 126-nt dsRNA substrate into 21-nt siRNAs on de-
naturing polyacrylamide gels. In mock-infected cell lysates,
dsRNA was efficiently processed into siRNAs (Figure 4A,
lane 3), whereas siRNA production was completely blocked
in lysates from IIV-6-infected cells (MOI of 1.0) (Figure 4A,
lane 7). Using a mixture of IIV-6 and mock-infected cell
lysates at different ratios, dsRNA processing was inhibited
in a dose-dependent manner (Figure 4A, lanes 4–6). Similar
results were observed in lysates from cells that were infected
with IIV-6 at an MOI of 0.1 (Figure 4A, lanes 9–13), al-
beit that Dicer activity was not completely blocked at this
lower MOI (Figure 4A, compare lane 13 with lane 7). To-
gether, these results indicate that IIV-6 encodes an inhibitor
of dsRNA processing.
We next tested our hypothesis that the 340R protein
interferes with Dcr-2-mediated dsRNA processing. Long
dsRNA was efficiently processed into siRNAs in non-
supplemented S2 cell extracts and in extracts supplemented
with recombinant MBP (Figure 4B, lanes 3 and 4). WT
340R inhibited processing of long dsRNA in a dose-
dependent manner (Figure 4B, lanes 6–8). Likewise, the ad-
dition of recombinant DCV 1A, a VSR that is known to
bind long dsRNA (11), completely blocked dsRNA cleav-
age (Figure 4B, lane 5). In contrast, the K89A or dsRBD100
mutants could not prevent the production of siRNAs, even
at the highest concentration tested (Figure 4B, lanes 9–11
and 12–14, respectively). It is worthwhile noting that the
K89A mutant does show dsRNA-binding activity in EM-
SAs (Figure 3A, lanes 11–14), but that it does not protect
dsRNA from Dicer-mediated processing (Figure 4B, lanes
9–11). Altogether, these data indicate that WT 340R inter-
feres with Dcr-2-dependent siRNA biogenesis and that effi-
cient dsRNA binding is required to prevent Dcr-2 process-
ing activity.
340R does not inhibit AGO2 slicing activity
Having shown that 340R interferes with the initiation steps
of the RNAi pathway, we wondered whether 340R also in-
hibits the effector phase of the RNAi response. We thus
monitored slicing of a radioactively 5′ cap-labeled target
RNA (44) in the presence or absence of 340R. Drosophila
embryo lysates were incubated with a 492-nt Fluc target
RNA sequence and a Fluc-specific siRNA that triggers tar-
get RNA cleavage into a 164-nt 5′ cleavage product (Figure
5A, lane 2). This specific cleavage product was not detected
after incubation with a non-specific control siRNA (Fig-
ure 5A, lane 1). In a first approach, we analyzed whether
340R interferes with RISC assembly and subsequent tar-
get RNA cleavage. To this end, we incubated recombinant
proteins with embryo lysate before the addition of siRNAs
(27). Using this approach, we observed that WT 340R effi-
ciently inhibited target RNA cleavage (Figure 5A, lane 4).
In contrast, the K89A and dsRBD100 mutants did not sup-
press slicing (Figure 5A, lanes 5 and 6), similar to MBP
alone (lane 3). To differentiate between the effect of 340R
onRISC assembly and target slicing, we next testedwhether
WT 340R affects slicing by interfering with a pre-assembled
RISC. To allow mature RISC formation, we pre-incubated
embryo extracts with siRNAs before the addition of 340R.
Neither MBP alone (Figure 5B, lane 3) nor WT or mutant
340R (lanes 4–6) inhibited target RNA cleavage under these
conditions. In contrast, the positive control Nora virus VP1
efficiently inhibited AGO2-mediated target cleavage in both
experimental approaches (Figure 5A and B, lane 7) (27).
These results demonstrate that 340R does not inhibit the ac-
tivity of a pre-assembledmature RISC. Because 340R binds
siRNAs (Figure 3C andD), we propose that 340R interferes
with the RISC assembly process by preventing siRNA load-
ing into AGO2.
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3–8) or protein storage buffer (lanes 1 and 2), followed by the addition of Fluc-specific siRNAs (siFluc, lanes 2–8) or non-specific control siRNAs (siCtrl,
lane 1). After another 30-min incubation, a radioactive cap-labeled Fluc target RNA was added to the reaction mixture. Target cleavage was analyzed on a
denaturing gel after a further 2-h incubation. (B) Slicer assay to monitor the effect of WT 340R on Slicer activity of a pre-assembled RISC. Recombinant
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IIV-6 340R rescues replication of aVSR-defective FHV repli-
con
To analyze whether the 340R-mediated VSR activity is suf-
ficient to suppress an antiviral RNAi response, we inves-
tigated whether 340R can rescue replication of a VSR-
defective FHV replicon (12,34). The WT replicon consists
of RNA1 of FHV, which encodes the viral RNA-dependent
RNA polymerase (RdRP) and expresses the B2 suppres-
sor protein that antagonizes RNAi by binding dsRNA
and siRNA duplexes (Figure 6A) (12,14,15). In the VSR-
defective FHV replicon (FHV B2), two-point mutations
were introduced that abolish B2 expression, resulting in an
RNAi-dependent replication defect (Figure 6A) (12,43,49).
We first analyzed whether CrPV 1A can rescue the repli-
cation defect of the FHV B2 replicon. We performed RT-
qPCR analysis to determine FHVRNA levels and observed
that the FHVB2 replicon replicates efficiently whenCrPV
1A is expressed (∼170-fold increase over the empty vector
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Figure 6. 340R rescues VSR-deficient FHV replication. (A) Schematic
representation of the WT and B2 FHV replicons. FHV RNA1 is self-
replicating and encodes the RNA-dependent RNA polymerase (RdRP).
B2, the viral suppressor of RNAi, is expressed from a subgenomic RNA
(upper panel). The FHV B2 replicon lacks B2 expression due to point
mutations (triangles) that disrupt the start codon (M1S) and introduce a
premature stop codon (S58*) (bottom panel) (49). pMT, metallothionein
promoter; HdV, Hepatitis delta virus. (B) FHV RNA levels in S2 cells co-
transfected with the FHVB2 replicon and expression plasmids encoding
the indicated viral proteins. FHVRNA levels were analyzed by qRT-PCR,
normalized toRp49 and presented as fold change relative to the empty vec-
tor control. Bars represent the means and standard deviations of three in-
dependent samples. Viral RNA levels were compared to the control (empty
plasmid) with one-way ANOVA followed by a post hoc Dunnett’s test. *P
≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ns, not significant.
control, Figure 6B), confirming that the FHV B2 repli-
con is restricted by an AGO2-dependent antiviral RNAi re-
sponse. Next, we tested whether WT 340R and the K89A
mutant can rescue FHV B2 replication. Upon expression
of WT 340R, FHV RNA levels were 20-fold higher than in
cells transfected with the empty vector control (Figure 6B,
P= 0.018), whereas the K89A mutant was unable to rescue
FHV B2 replication (∼2-fold increase). In line with the
results of the RNAi reporter assays (Figure 1), the putative
RNase III 142R did not rescue FHV B2 replication. To-
gether, our results show that 340R suppresses the antiviral
RNAi pathway.
DISCUSSION
In recent years, it has become clear that different classes
of RNA viruses are targets of the RNAi pathway in
Drosophila. The antiviral activity of the RNAi machinery
is mediated by Dcr-2-dependent cleavage of viral dsRNA
into vsiRNAs that guide AGO2-dependent slicing of viral
single-stranded RNA (9,11,13,26,33,34,50). During the on-
going arms race between viruses and their hosts, viruses
have evolved sophisticated mechanisms to suppress or
evade host-based immune responses. The best-studied ex-
amples of viral antagonism of RNAi in Drosophila come
from studies on RNA viruses, which encode VSRs that
interfere with the initiation and effector phases of the
RNAi pathway (9). DNA viruses also induce an RNAi re-
sponse in Drosophila, which is initiated by processing of vi-
ral dsRNA substrates derived from overlapping convergent
transcripts (35,36) or from structured regions within viral
transcripts (51,52). However, it remained unclear whether
DNA viruses inhibit this small RNA-based immune re-
sponse in Drosophila. In this study, we show that the
dsRBD-containing protein 340R from theDNA virus IIV-6
suppresses RNAi.
IIV-6 is a nucleocytoplasmic virus that can infect
Drosophila-derived cells as well as adult flies (35,36,53,54).
This linear dsDNA virus contains 211 putative ORFs,
which are transcribed from either strand of the viral genome
(45,46). We show that RNAi is inhibited in IIV-6-infected
cells and demonstrate that the IIV-6-encoded 340R protein
inhibits Dcr-2 processing and RISC loading through du-
plex RNA binding. However, we cannot exclude the possi-
bility that IIV-6 produces additional VSRs that contribute
to RNAi antagonism. The plant RNA virus Citrus tristeza
virus, for example, encodes three distinct VSRs to inhibit
the antiviral RNAi response at different levels (55). Stud-
ies on Xenopus laevis RNA-binding protein (Xlrbp) and
Drosophila Staufen revealed that their dsRBDs alone are
sufficient to bind dsRNA (56–58). Surprisingly, however,
the C-terminal deletion mutant dsRBD100, which contains
the entire dsRBD, was unable to bind RNA duplexes and
did not exert VSR activity. How the C-terminal region of
340R contributes to VSR activity remains an open question
for further studies.
Viral RNase III proteins are conserved among all gen-
era within the Iridoviridae family, suggesting that this pro-
tein has important functions within the viral life cycle (46).
However, under our experimental conditions, the putative
RNase III 142R did not show VSR activity in reporter as-
says andwas not able to rescue FHVB2 replication. These
observations suggest that the IIV-6-encoded RNase III is
not involved in suppression of the RNAi response. This is
in contrast to the proposed VSR activity of the RNase III
proteins fromHeliothis virescens ascovirus-3e, aDNAvirus
that infects moths, and from the plant RNA virus Sweet
potato chlorotic stunt virus (24,25). 142R is structurally
similar to bacterial RNase III proteins that are involved in
the processing of structured, non-codingRNAs and specific
mRNAs (59). Similarly, Iridovirus-encoded RNase III pro-
teins may be in involved in the processing of viral or cellular
RNAs, rather than suppression of RNAi.
Viral dsRNA triggers a sequence-specific RNAi re-
sponse in invertebrates, but may additionally induce a
sequence-independent antiviral response in marine shrimp
(Litopenaeus vannamei) and honey bees (Apis mellifera)
(60,61). Notably, IIV-6 infects a broad range of inverte-
brate hosts under natural and experimental conditions, in-
cluding honey bees and penaeid shrimp (53,62,63). There-
fore, it will be interesting to analyze whether 340R (and
perhaps 142R) antagonizes putative dsRNA-induced tran-
scriptional responses in invertebrates.
In this study, we used RNAi reporter assays to detect
VSR activity for candidate proteins. However, these as-
says have their limitations, since they may fail to iden-
tify cis-acting VSRs (64) and host species-specific VSRs
(65). Moreover, these assays could identify VSR activity
of dsRNA-binding proteins that are unlikely to suppress
RNAi under natural conditions (66). To analyze whether vi-
ral dsRNA-binding proteins function as VSRs in vivo, it is
important to study replication of VSR-defective virus mu-
tants in an RNAi competent host as well as in an RNAi-
deficient host. Since no strategies are yet available to ge-
netically manipulate IIV-6, the role of 340R in infection
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remains to be established. Nevertheless, we demonstrated
that RNAi is suppressed in IIV-6-infected cells and that
340R, like other VSRs, rescues replication of FHV B2
(12,13,34,43,47,67–69), suggesting that 340R is a bona fide
VSR. We and others previously reported that the DNA
virus IIV-6 is restricted by an antiviral RNAi response
(35,36). Our finding that IIV-6 340R antagonizes RNAi
provides further support for an antiviral RNAi response to
DNA virus infection in insects.
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